Non-invasive forced expiratory flow–volume curves to measure lung function in cats

2007 ◽  
Vol 155 (1) ◽  
pp. 49-54 ◽  
Author(s):  
Hylton Bark ◽  
Ana Epstein ◽  
Ephraim Bar-Yishay ◽  
Alex Putilov ◽  
Simon Godfrey
1988 ◽  
Vol 138 (3) ◽  
pp. 590-597 ◽  
Author(s):  
Peter N. Le Souëf ◽  
Daniel M. Hughes ◽  
Louis I. Landau

2020 ◽  
Author(s):  
S. Anandh ◽  
R. Vasuki ◽  
Raid Saleem Al Baradie

The Biofeedback Expectorant is a device which is designed for patients sufferingfrom various lung disorders, associated with the production and secretion of excessivequantities of mucus within the airways and help to loosen the mucous so that it tendsto be hacked from the lungs. Meanwhile, the mucous in the lungs becomes thick anddifficult to wash out from the air routes. When this mucous remain in the air routes, itblocks airways and becomes hard to relax. The disease is likely to be conceivable ifthe mucous remains permanently in the air routes. When one breathes out through thisdevice, it bounces the ball inside to it. This action produces signals around 15 Hz andforward the vibration via the air ways. This amalgamation of enhanced intensity andvibration aids the mucous in moving into the air ways where it remains. Some patientscan’t blow for a longer duration, therefore a feedback system is designed in such away that the pressure is measured using a pressure sensor. If the value goes below thecertain threshold limit the beep sound is heard and a light indication is provided sothat we can find whether the patient should blow effectively. The Blowing time (howmuch time duration the patient is blowing) was measured and display in the LCDscreen. The forced expiratory flow volume (FEV1) and Peak Expiratory Flow Rate(PEFR) was calculated that gives an idea about the status of the lungs. The MannWhitney U Test was conducted with α = 0.05 for the sampled data, the results showthat the data is statistically significant. This device is small, portable, and easy to usewith no side effects.


CHEST Journal ◽  
2005 ◽  
Vol 128 (4) ◽  
pp. 187S
Author(s):  
Caroline Pesant ◽  
Miriam Santachi ◽  
Mario Geoffroy ◽  
Theophile Niyonsega ◽  
Mario E. Dumas ◽  
...  

1993 ◽  
Vol 75 (4) ◽  
pp. 1720-1727 ◽  
Author(s):  
R. Pellegrino ◽  
B. Violante ◽  
S. Nava ◽  
C. Rampulla ◽  
V. Brusasco ◽  
...  

To investigate the role of airflow limitation on the increase of end-expiratory lung volume (EELV) during bronchoconstriction, nine stable asthmatic subjects and seven healthy subjects were challenged with inhaled methacholine (MCh). Changes in airway caliber were assessed by using forced expiratory volume in 1 s, partial forced expiratory flow at 50% of control forced vital capacity, and specific airway conductance. To detect airflow limitation, tidal flow-volume curves were superimposed on partial forced flow-volume curves at absolute lung volume. The electromyogram of the diaphragm was recorded by surface electrodes in four asthmatic and four healthy subjects, and the electrical diaphragmatic activity (DIA) during expiration was expressed as a percentage of the duration of expiratory time. In 10 subjects (9 asthmatic and 1 healthy) the partial forced expiratory flow recorded after some MCh dose impinged on tidal expiratory flow recorded before MCh. When this occurred it was associated with an increase in EELV by 0.54 +/- 0.07 (SE) liter (P < 0.001), which was larger than that occurring when lower MCh doses (0.11 +/- 0.04 liter, P < 0.05) were used, and with a moderate increase in DIA of 15 +/- 2.5% (P < 0.01). Six healthy subjects did not increase EELV after MCh despite a significant degree of bronchoconstriction; in these subjects tidal expiratory flow never impinged on forced expiratory flow, and DIA never increased. These results suggest that hyperinflation during MCh-induced bronchoconstriction is triggered by dynamic compression of the airways and is associated with moderate increase of DIA during expiration.


1993 ◽  
Vol 74 (6) ◽  
pp. 2681-2686 ◽  
Author(s):  
R. Pellegrino ◽  
B. Violante ◽  
E. Crimi ◽  
V. Brusasco

To investigate whether histamine (His) and methacholine (MCh) have different effects on airways and lung parenchyma, 11 healthy subjects were given aerosol MCh until a response plateau was obtained and then two doses of His. At the plateau, forced expiratory volume in 1 s and forced expiratory flow at 40% of vital capacity from partial flow-volume curves were reduced by 19 +/- 3 (SE) and 80 +/- 4%, respectively. Aerosol His decreased forced expiratory volume in 1 s by an additional 12 +/- 1% but left partial forced expiratory flow unchanged. The bronchodilator effect of deep inhalation, as inferred from the ratio of forced expiratory flow from maximal to that from partial flow-volume curves, increased after MCh and plateaued but decreased after His. Quasi-static transpulmonary pressure-volume area determined in seven subjects was unchanged after MCh but was increased by 57 +/- 10% after His. We conclude that adding His after the response to MCh plateaued does not increase the maximal degree of bronchoconstriction but may increase parenchymal hysteresis, thus blunting the bronchodilator effect of deep inhalation. These results suggest that His and MCh have similar effects on airway smooth muscle but different effects on lung tissue properties.


1987 ◽  
Vol 63 (1) ◽  
pp. 44-50 ◽  
Author(s):  
D. L. Shulman ◽  
E. Bar-Yishay ◽  
C. S. Beardsmore ◽  
B. Beilin ◽  
S. Godfrey

Maximal flows at functional residual capacity (VmaxFRC) from partial forced expiratory flow-volume (PEFV) curves were obtained in 14 normal preschool children (8 boys, 6 girls) of average age 44 mo, under general anesthesia before elective surgery. PEFV curves were generated from end inspiration by rapid compression of the chest wall with an inflatable jacket. VmaxFRC, expressed in milliliter per second, correlated linearly with height, weight, age, and FRC in milliliter and milliliters per kilogram. The best correlation of VmaxFRC (ml/s) was to height to the power of 2.47, which agrees with the results predicted by wave-speed theory. Mean FRC-corrected VmaxFRC was 2.42 +/- 0.50 (SD) FRC's/s with no significant difference between boys (2.35 FRC's/s) and girls (2.51 FRC's/s). There was no correlation between lung-size corrected VmaxFRC and height, weight, or age, but it tended to decrease with increasing FRC. The intersubject variability for VmaxFRC was reduced by normalizing for FRC, and was significantly better than that reported for awake children. This can be attributed to the greater control over volume history and more reliable maximal flow generation during anesthesia. The intrasubject coefficient of variation (CV) for VmaxFRC was 12.2%, and the intersubject CV was 20.0%. The difference may represent the variability due to dysanapsis. It is concluded that dysanapsis is not a prominent factor in children of this age group. In addition, the similarity of the regression equation for VmaxFRC vs. height to that of FRC vs. height supports the concept of equidimensional growth of the airways and lung parenchyma.


1987 ◽  
Vol 62 (9) ◽  
pp. 895-900 ◽  
Author(s):  
E W Hoskyns ◽  
A D Milner ◽  
I E Hopkin

Sign in / Sign up

Export Citation Format

Share Document